Skin Disorders News

Children who were raised in rural environments with lots of time outdoors and some exposure to animals had immune systems that were better regulated than children raised in urban environments, according to a study published in Allergy.

Positive top-line results from two phase 3 studies show remibrutinib yielded statistically significant improvements in disease severity among patients with chronic spontaneous urticaria, Novartis announced in a press release.

Pediatric patients with atopic dermatitis whose pruritus has not been successfully controlled with topical treatments have seen success with nemolizumab, according to a study.

Patterns of pediatric allergy demonstrated a population-level progression of diseases in an atopic march from eczema to food allergies, asthma and environmental allergies, according to a study published in Pediatrics.

Patients with hereditary angioedema experience significant burdens in disease control, quality of life, treatment satisfaction and societal costs, reported a study published in The Journal of Allergy and Clinical Immunology: In Practice.

The FDA has granted fast-track status to STAR-0215, a potential first-line treatment to prevent attacks of hereditary angioedema, Astria Therapeutics Inc. announced in a company press release.

Sexually diverse individuals are at an increased risk for atopic diseases, including asthma, allergic rhinitis and atopic dermatitis, according to a research letter.

CHICAGO — By protecting the skin barrier against atopic dermatitis, physicians may prevent food allergy as well, according to a presentation at the Global Food Allergy Prevention Summit.

Alphyn Biologics announced new data from its phase 2a clinical trial evaluating topical AB-101a for the treatment of mild to moderate atopic dermatitis in patients aged as young as 2 years, according to a company release.

CHICAGO — Allergists treating atopic dermatitis might consider focusing on the skin microbiome to improve outcomes, according to a presenter at the Global Food Allergy Prevention Summit.